Format
Sort by

Send to

Choose Destination

Search results

Items: 18

1.

Treatment of a multiple sclerosis animal model by a novel nanodrop formulation of a natural antioxidant.

Binyamin O, Larush L, Frid K, Keller G, Friedman-Levi Y, Ovadia H, Abramsky O, Magdassi S, Gabizon R.

Int J Nanomedicine. 2015 Nov 20;10:7165-74. doi: 10.2147/IJN.S92704.

2.

Nitric oxide secretion in human conjunctival fibroblasts is inhibited by alpha linolenic acid.

Erdinest N, Shohat N, Moallem E, Yahalom C, Mechoulam H, Anteby I, Ovadia H, Solomon A.

J Inflamm (Lond). 2015 Oct 25;12:59. doi: 10.1186/s12950-015-0104-1.

3.

Nano-Drugs Based on Nano Sterically Stabilized Liposomes for the Treatment of Inflammatory Neurodegenerative Diseases.

Turjeman K, Bavli Y, Kizelsztein P, Schilt Y, Allon N, Katzir TB, Sasson E, Raviv U, Ovadia H, Barenholz Y.

PLoS One. 2015 Jul 6;10(7):e0130442. doi: 10.1371/journal.pone.0130442.

4.

Antineoplastic effect of decoy oligonucleotide derived from MGMT enhancer.

Canello T, Ovadia H, Refael M, Zrihan D, Siegal T, Lavon I.

PLoS One. 2014 Dec 2;9(12):e113854. doi: 10.1371/journal.pone.0113854.

5.

Anti-inflammatory effects of resolvin-D1 on human corneal epithelial cells: in vitro study.

Erdinest N, Ovadia H, Kormas R, Solomon A.

J Inflamm (Lond). 2014 Mar 2;11(1):6. doi: 10.1186/1476-9255-11-6.

6.

Expression and activation of toll-like receptor 3 and toll-like receptor 4 on human corneal epithelial and conjunctival fibroblasts.

Erdinest N, Aviel G, Moallem E, Anteby I, Yahalom C, Mechoulam H, Ovadia H, Solomon A.

J Inflamm (Lond). 2014 Feb 4;11(1):3. doi: 10.1186/1476-9255-11-3.

7.

Glucocorticosteroids in nano-sterically stabilized liposomes are efficacious for elimination of the acute symptoms of experimental cerebral malaria.

Waknine-Grinberg JH, Even-Chen S, Avichzer J, Turjeman K, Bentura-Marciano A, Haynes RK, Weiss L, Allon N, Ovadia H, Golenser J, Barenholz Y.

PLoS One. 2013 Aug 26;8(8):e72722. doi: 10.1371/journal.pone.0072722.

8.

Interleukin-1β regulates fat-liver crosstalk in obesity by auto-paracrine modulation of adipose tissue inflammation and expandability.

Nov O, Shapiro H, Ovadia H, Tarnovscki T, Dvir I, Shemesh E, Kovsan J, Shelef I, Carmi Y, Voronov E, Apte RN, Lewis E, Haim Y, Konrad D, Bashan N, Rudich A.

PLoS One. 2013;8(1):e53626. doi: 10.1371/journal.pone.0053626.

9.

Targeting of prion-infected lymphoid cells to the central nervous system accelerates prion infection.

Friedman-Levi Y, Hoftberger R, Budka H, Mayer-Sonnenfeld T, Abramsky O, Ovadia H, Gabizon R.

J Neuroinflammation. 2012 Mar 21;9:58. doi: 10.1186/1742-2094-9-58.

10.

Increased adipocyte S-nitrosylation targets anti-lipolytic action of insulin: relevance to adipose tissue dysfunction in obesity.

Ovadia H, Haim Y, Nov O, Almog O, Kovsan J, Bashan N, Benhar M, Rudich A.

J Biol Chem. 2011 Sep 2;286(35):30433-43. doi: 10.1074/jbc.M111.235945.

11.

Serum S100B levels after meningioma surgery: A comparison of two laboratory assays.

Einav S, Itshayek E, Kark JD, Ovadia H, Weiniger CF, Shoshan Y.

BMC Clin Pathol. 2008 Sep 19;8:9. doi: 10.1186/1472-6890-8-9.

12.

Fatal neurological disease in scrapie-infected mice induced for experimental autoimmune encephalomyelitis.

Friedman-Levi Y, Ovadia H, Hoftberger R, Einstein O, Abramsky O, Budka H, Gabizon R.

J Virol. 2007 Sep;81(18):9942-9.

13.
14.
15.

Treatment of chronic-relapsing experimental autoimmune encephalomyelitis with the synthetic immunomodulator linomide (quinoline-3-carboxamide).

Karussis DM, Lehmann D, Slavin S, Vourka-Karussis U, Mizrachi-Koll R, Ovadia H, Kalland T, Abramsky O.

Proc Natl Acad Sci U S A. 1993 Jul 15;90(14):6400-4.

16.

Neural responses to antigenic challenges and immunomodulatory factors.

Saphier D, Ovadia H, Abramsky O.

Yale J Biol Med. 1990 Mar-Apr;63(2):109-19.

18.
Items per page

Supplemental Content

Loading ...
Support Center